miR Advantage
Science
About Us
Press
Careers
Contact Us
English
Spanish
English
miR News & Events
Press Releases
February 25, 2021
miR Scientific to Present the Prostate Cancer Application of its Liquid Biopsy miR Disease Management Platform® at the 12th Annual Prostate Cancer Awareness Day (PCAD) at the Massachusetts State House
January 11, 2021
miR Scientific to Present the Prostate Cancer Application of its Liquid Biopsy Disease Management Platform at the 39th Annual J.P. Morgan Healthcare Conference
November 2, 2020
miR Scientific and Puerto Rico Government Announce Pioneering Cooperation Agreement to Evaluate Impact and Deployment of its Prostate Cancer Liquid Biopsy Test in Puerto Rico
November 2, 2020
miR Scientific y el gobierno de Puerto Rico anuncian un convenio de cooperación sin precedentes para la evaluación del impacto y el despliegue de su prueba de biopsia líquida de cáncer de próstata en Puerto Rico
October 13, 2020
miR Scientific announces FDA Breakthrough Device Designation for its Prostate Cancer Liquid Biopsy Test
September 14, 2020
miR Scientific's Breakthrough Sentinel Disease Management Platform Receives 2020 Innovation Award
September 8, 2020
miR Scientific on Yahoo Finance
August 10, 2020
miR Scientific Announces Validation of its Urine Based, Non-Invasive Prostate Cancer Test Published in the Journal of Urology
August 2, 2020
miR Scientific Named a Finalist in the Fierce Innovation Awards - Life Sciences Edition 2020
February 13, 2020
miR Scientific Presents Breakthrough New Data on the miR Scientific Sentinel™
January 21, 2020
miR Scientific® Introduces New Paradigm for Precision Medicine at PMWC 2020
March 18, 2019
miR Scientific Presents a New Non-invasive Test for Identifying Clinically Significant Prostate Cancer
July 20, 2018
miR Scientific to Present Novel Array Technologies for Diagnosis and Prognosis of Urogenital Cancers at the 2018 ASCO Annual Meeting
July 9, 2018
miR Scientific Appoints Laurence Klotz, M.D., FRCSC, as Chief Medical Officer
Media
March 29, 2021
Prostatepedia March 2021: Sam Salman, Urine-based Liquid Biopsy Testing
November 19, 2020
Puerto Rico to Test miR’s ‘Liquid Biopsy’ in Detecting Prostate Cancers
October 26, 2020
FDA grants breakthrough designation to urine-based liquid biopsy for prostate cancer
August 14, 2020
Classification of Prostate Cancer Using Tests for Small Noncoding RNAs in Urinary Exosomes
August 11, 2020
Forbes: A Test Affecting Every Man’s Life Will Soon Be On The Market
April 6, 2020
miR Scientific Validates Urine-Based Cancer Tests, Awaits NYState Approval
March 6, 2020
3 New miR Scientific Urine Tests Diagnose, Classify Prostate Cancer, Data Shows
April 15, 2019
miR Scientific: Spotting Aggression With RNA in Urine
March 28, 2019
miR Scientific Prepares to Launch Tests for Prostate, Bladder Cancer
October 4, 2018
miR Scientific Presents at 2018 World Urological Oncology Federation Conference
July 20, 2018
miR Scientific Prepares Launch of First Clinical Cancer Test, Buoyed by New Data